Patents and patients: the implications of the Prometheus v. Mayo Supreme Court decision.
作者信息
Rasheed Nabeela
机构信息
McAndrews, Held & Malloy, Chicago, USA.
出版信息
MLO Med Lab Obs. 2012 Jul;44(7):60-1.
PMID:22852222
Abstract
摘要
相似文献
1
Patents and patients: the implications of the Prometheus v. Mayo Supreme Court decision.
MLO Med Lab Obs. 2012 Jul;44(7):60-1.
2
Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.普罗米修斯公司案：最高法院重新界定诊断发明的可专利性。
Recent Pat DNA Gene Seq. 2012 Dec;6(3):193-6. doi: 10.2174/187221512802717330.
3
Patent watch: Supreme Court decision impacts the strength of US patents.
Nat Rev Drug Discov. 2016 Jul 29;15(8):524. doi: 10.1038/nrd.2016.149.
4
Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?梅奥诊所、Myriad公司、《美国发明法案》和《生物制剂价格竞争与创新法案》：美国生物制药市场受到了怎样的影响？
Pharm Pat Anal. 2016 May;5(3):159-67. doi: 10.4155/ppa-2016-0005. Epub 2016 Apr 18.
5
Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?诊断技术的专利保护：美国最高法院近期的裁决会改变专利策略吗？
Pharm Pat Anal. 2015;4(5):357-62. doi: 10.4155/ppa.15.22. Epub 2015 Oct 9.
6
Supreme Court reins in ambiguous patents.最高法院对模糊不清的专利加以控制。
Nat Rev Drug Discov. 2014 Jul;13(7):488. doi: 10.1038/nrd4384.
7
Prometheus and Bilski: pushing the bounds of patentable subject matter in medical diagnostic techniques with the machine-or-transformation test.
Am J Law Med. 2010;36(4):619-51. doi: 10.1177/009885881003600404.
8
The patent eligibility of diagnostic methods after Prometheus: a redefined test for transformation.
Health Matrix Clevel. 2013;22(2):589-624.
9
Implications of recent US Supreme Court IP ruling for nanomedicine patents.
Nanomedicine (Lond). 2008 Apr;3(2):141-3. doi: 10.2217/17435889.3.2.141.
10
US Supreme Court applies strict limits to patents.美国最高法院对专利施加严格限制。
Nat Biotechnol. 2002 Jul;20(7):639. doi: 10.1038/nbt0702-639a.
Zotero 插件